The agency's approval of the Pfizer-BioNTech vaccine — shown to be 95% effective — would go beyond the speedier and less rigorous emergency use authorization currently granted to the vaccine.

(Image credit: Ben Hasty/MediaNews Group/Reading Eagle via Getty Images)